Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UP-KNEE: Bupivacaine for Knee OA Pain
NCT05561010Unknown
- Sponsor
- Nottingham University Hospitals
- Start
- Oct 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in osteoarthritis (OA) comparing Bupivacaine with Placebo (2 arms). Primary endpoints: Change from baseline in pain score during the six-minute walk test at 1 hour and Change from baseline in pain score at rest at 1 hour. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05561010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05561010.